Germany will be the first EU country to use the experimental antibody-based treatment administered to Donald Trump against Covid-19.
This was announced by German Health Minister Jens Spahn.
“The government has purchased 200,000 doses for 400 million euros,” he told the newspaper Bild am Sonntag. This mix of “monoclonal” antibodies will be used in university hospitals next week, he added.
by Xavier Cuesta – European Correspondent – EN